[144] CeriBell, Inc. SEC Filing
CeriBell, Inc. filed a Form 144 notifying the proposed sale of 11,112 common shares via Fidelity Brokerage Services on or about 09/04/2025 on the NASDAQ. The filing reports an aggregate market value of $134,609.87 against 36,663,968 shares outstanding, indicating the shares represent approximately 0.03% of the outstanding common stock. The shares arise from option exercises: 1,472 shares from an option granted 07/07/2021 and 9,640 shares from an option granted 02/16/2023, with cash payment recorded on 09/04/2025. The filer reports no sales in the prior three months. The form contains standard representations about material nonpublic information and signature attestation.
- None.
- None.
Insights
TL;DR: Small insider sale from exercised options; immaterial to market capitalization but relevant for short-term float.
The filing documents a planned sale of 11,112 shares worth $134,609.87, which is roughly 0.03% of the issuer's 36.66 million shares outstanding. These shares result from option exercises granted in 2021 and 2023 and will be sold through Fidelity on NASDAQ. From a capital-structure perspective, the amount is negligible relative to total outstanding shares and unlikely to move the stock price materially. The disclosure complies with Rule 144 timeliness and includes the standard attestation regarding material nonpublic information.
TL;DR: Filing meets Rule 144 disclosure norms; exercise-and-sale indicates routine insider liquidity, not an unusual governance event.
The notice indicates securities acquired via options and being sold shortly after exercise with cash payment recorded. The filer discloses no related sales in the past three months and includes the required attestations. This is a routine compliance disclosure showing an insider monetizing vested equity rather than signaling governance changes or unexpected departures.